Cardiovascular Health

Can Probiotics Regulate Lipid Metabolism?

By Carrie Decker, ND, Contributing Writer

There’s ample data to show that gut bacteria affect mood, immune system health, sleep cycles, and response to stress. It turns out that the gut microbiome—at least certain microbial species within it—also play a role in lipid metabolism, suggesting that some types of probiotics may have heart health benefits.

Is Leaky Gut a Cardiovascular Risk Factor?

By Becky Wright, Contributing Writer

Leaky gut syndrome has been getting a lot of attention during the last several years for its role in the etiology of chronic conditions like inflammatory bowel syndrome (IBS) and even diabetes. A new line of research suggests that intestinal permeability may contribute to cardiovascular risk. The key? Gut bacteria and bacterial endotoxins that enter the blood stream and inflitrate the epicardium, the vascular endothelium, and atheromatous plaques present in the vessels.

Choline, Carnitine & the Heart: Is TMAO Really a Risk Factor?

By Russell Jaffe, MD, Contributing Writer

Recently, I was asked if I had any concerns about elevated levels of TMAO—trimethylamine N-oxide--with a diet high in eggs. This is a reasonable question given that elevated TMAO levels have been linked to increased cardiovascular disease and stroke. As with most physiologic functions, however, the answer is nuanced and highly individualized. It’s not a simple “good or bad” subject.

To Reduce Age-Related Heart Risk, Target the Mitochondria

By August West, Contributing Writer

It’s an unfortunate fact of nature: mitochondrial function tends to decline with age. Along with that comes a host of physiological changes that cumulatively result in the phenomenon we all experience as aging and senescence. Fortunately, a new form of mitochondrially-targeted co-enzyme Q10 can reverse some of these changes. 

Is Galectin-3 Inhibition a Key to Reducing Heart Failure?

By Isaac Eliaz, MD, LAc, Contributing Writer

A fast-growing body of data points to galectin-3 (Gal-3) -- an adhesive cell surface protein—as a potential therapeutic target for reducing cardiovascular morbidity and mortality. Modified Citrus Pectin, a natural substance derived from citrus fruit peels, is the only known natural compound that can bind Gal-3, potentially reducing CVD risk.

Two Landmark Studies Shed New Light--and Shadow-- on Omega-3s for CVD

By William H. Harris, PhD, Contributing Writer

Two pivotal studies on omega-3s —the long awaited REDUCE-IT and VITAL trials, attempt to clarify the clinical roles of omega-3s for cardiovascular risk reduction. While many of the mainstream headlines took a negative view of the findings, the data actually show some meaningful benefits from omega-3s. Dr. Bill Harris, developer of the Omega-3 Index test, weighs in on the negative and positive messags of these important studies.

"Cleaner" Proteins Scrub Arteries, Reduce Cardiovascular Risk

By Jessica Best, Contributing Writer

Patients at risk of atherosclerosis may have new hope for cleaner arteries thanks to a naturally occurring “scrubber” protein that exists within the body. Alpha-1-microglobin (A1M), referred to as a "circulating wastebasket," scavenges free radicals as well as blood fats that have already been oxidized, potentially opening up a new avenue for reversing atherosclerosis.